Save your place

Sign in to WhoBought

Please try again later.

Ken Fisher's Vir Biotechnology, Inc. (VIR) position

Not anymore: Ken Fisher fully exited VIR in Q3 2023. The position peaked at an amount we cannot price in Q2 2023.
View full portfolio →
Value at exit
an amount we cannot price
Shares at exit
253
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

VIR price vs Fisher's position

Dates
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q3 2023 Exited −253 −100.0% 0 Nov 13, 2023
Q2 2023 New +253 253 Dec 12, 2023
Data through Q3 2023 · filed Nov 13, 2023
2 grouped rows from 2 quarters

More Fisher positions

Common questions

Does Ken Fisher own VIR?

Not currently. Ken Fisher fully exited VIR in Q3 2023, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ken Fisher buy VIR?

Ken Fisher first disclosed a VIR position in Q2 2023; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ken Fisher sell VIR?

Yes. Ken Fisher reduced and then fully exited VIR by Q3 2023; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of VIR does Ken Fisher own?

None as of the latest filing: Ken Fisher has exited VIR. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ken Fisher pay for VIR?

Ken Fisher began building the VIR position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.